{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:19:10Z","timestamp":1790983150045,"version":"4.1.0"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T00:00:00Z","timestamp":1787011200000},"content-version":"vor","delay-in-days":229,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2026]]},"DOI":"10.1016\/j.idcr.2026.e02735","type":"journal-article","created":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T07:03:00Z","timestamp":1787122980000},"page":"e02735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma"],"prefix":"10.1016","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-2707-8472","authenticated-orcid":false,"given":"Yuichi","family":"Horigome","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yusuke","family":"Michishita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momo","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuro","family":"Yanagida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Konishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichi","family":"Ehata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kei","family":"Hayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotoshi","family":"Kamata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Miyazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahiro","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.idcr.2026.e02735_bib1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3324\/haematol.2024.285645","article-title":"Risk of infections in multiple myeloma. A population-based study on 8,672 multiple myeloma patients diagnosed 2008-2021 from the Swedish Myeloma Registry","volume":"110","author":"Blimark","year":"2025","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02735_bib2","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1016\/S2352-3026(21)00283-0","article-title":"Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group","volume":"9","author":"Raje","year":"2022","journal-title":"Lancet Haematol"},{"issue":"8","key":"10.1016\/j.idcr.2026.e02735_bib3","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.3390\/v17081135","article-title":"Disseminated varicella-zoster virus infection with internal organ involvement: a scoping review of 156 cases","volume":"17","author":"Timotijevic","year":"2025","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.idcr.2026.e02735_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imr.12389","article-title":"Monoclonal antibodies targeting CD38 in hematological malignancies and beyond","volume":"270","author":"van de Donk","year":"2016","journal-title":"Immunol Rev"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02735_bib5","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1182\/blood-2015-12-687749","article-title":"Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma","volume":"128","author":"Krejcik","year":"2016","journal-title":"Blood"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02735_bib6","doi-asserted-by":"crossref","first-page":"81","DOI":"10.55729\/2000-9666.1462","article-title":"The unusual suspect - herpes zoster as the culprit for severe abdominal Pain. A case report","volume":"15","author":"Lovering","year":"2025","journal-title":"J Community Hosp Intern Med Perspect"},{"key":"10.1016\/j.idcr.2026.e02735_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.idcr.2025.e02317","article-title":"A case of acute abdomen caused by visceral disseminated varicella-zoster virus infection causes diagnostic challenges during the course of systemic lupus erythematosus","volume":"41","author":"Matsushita","year":"2025","journal-title":"IDCases"},{"issue":"3","key":"10.1016\/j.idcr.2026.e02735_bib8","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s12328-022-01607-7","article-title":"Visceral disseminated varicella-zoster virus infection in an immunocompetent host","volume":"15","author":"Matsuo","year":"2022","journal-title":"Clin J Gastroenterol"},{"issue":"4","key":"10.1016\/j.idcr.2026.e02735_bib9","doi-asserted-by":"crossref","first-page":"292","DOI":"10.32552\/2024.ActaMedica.995","article-title":"Daratumumab-associated varicella-zoster virus meningoencephalitis in relapsed refractory multiple myeloma","volume":"55","author":"Turgutkaya","year":"2024","journal-title":"Acta Med"},{"issue":"11","key":"10.1016\/j.idcr.2026.e02735_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofac574","article-title":"Cumulative incidence and relative risk of infection in patients with multiple myeloma treated with anti-CD38 monoclonal antibody-based regimens: a systematic review and meta-analysis","volume":"9","author":"Vassilopoulos","year":"2022","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.idcr.2026.e02735_bib11","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2147\/CCID.S464039","article-title":"Death caused by disseminated herpes zoster in a patient with multiple myeloma: a case report and literature review","volume":"17","author":"Bo","year":"2024","journal-title":"Clin Cosmet Investig Dermatol"},{"issue":"10","key":"10.1016\/j.idcr.2026.e02735_bib12","article-title":"Atypical presentation of disseminated varicella zoster virus infection mimicking bullous pemphigoid","volume":"16","author":"Timotijevic","year":"2024","journal-title":"Cureus"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02735_bib13","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41375-020-0855-4","article-title":"Deep immune profiling of patients treated with lenalidomide and dexamethasone with or without daratumumab","volume":"35","author":"Casneuf","year":"2021","journal-title":"Leukemia"},{"issue":"22","key":"10.1016\/j.idcr.2026.e02735_bib14","doi-asserted-by":"crossref","first-page":"5895","DOI":"10.1158\/1078-0432.CCR-20-1781","article-title":"Immunomodulation in pomalidomide, dexamethasone, and daratumumab-treated patients with relapsed\/refractory multiple myeloma","volume":"26","author":"Pierceall","year":"2020","journal-title":"Clin Cancer Res"},{"issue":"23","key":"10.1016\/j.idcr.2026.e02735_bib15","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1182\/bloodadvances.2017006866","article-title":"Effects of daratumumab on natural killer cells and impact on clinical outcomes in relapsed or refractory multiple myeloma","volume":"1","author":"Casneuf","year":"2017","journal-title":"Blood Adv"},{"issue":"6","key":"10.1016\/j.idcr.2026.e02735_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S1470-2045(21)00128-5","article-title":"Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial","volume":"22","author":"Dimopoulos","year":"2021","journal-title":"Lancet Oncol"},{"issue":"19","key":"10.1016\/j.idcr.2026.e02735_bib17","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1056\/NEJMoa1805762","article-title":"Elotuzumab plus pomalidomide and dexamethasone for multiple myeloma","volume":"379","author":"Dimopoulos","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.idcr.2026.e02735_bib18","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1007\/s12185-025-03980-8","article-title":"Incidence of herpes zoster in transplant-ineligible patients with newly diagnosed multiple myeloma treated with daratumumab, lenalidomide, and dexamethasone","volume":"122","author":"Horigome","year":"2025","journal-title":"Int J Hematol"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2214250926002489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:14:55Z","timestamp":1790723695000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2214250926002489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":18,"alternative-id":["S2214250926002489"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02735","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disseminated varicella-zoster virus infection with gastrointestinal prodromal symptoms during daratumumab therapy for relapsed and refractory multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2026.e02735","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02735"}}